Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_assertion description "[Adjunctive therapy with recombinant human IGF-I (rhIGF-I)/recombinant human IGF binding protein-3 (rhIGFBP-3) has been shown to improve insulin sensitivity in both type 1 and type 2 diabetes and may have a role in the treatment of SIR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_assertion evidence source_evidence_literature NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_assertion SIO_000772 20233784 NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_assertion wasDerivedFrom befree-20140225 NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_assertion wasGeneratedBy ECO_0000203 NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP414688.RAuCwhiQXyRDS_JAMi5RJt_AgLY9rKh4exnOjbHlnfgIg130_provenance.